The at-home FluMist vaccine will be for patients ages 2 to 49 years old. Patients can place an order online, complete a ...
These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
FluMist, the nasal flu vaccine spray, was approved in September by the U.S. Food and Drug Administration for at-home use starting in fall 2025. Currently, it can only be administered by a healthcare ...
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
FluMist was first approved for at-home use in September by the U.S. Food ... If you have plans to get FluMist nasal spray, you should not take any antiviral medication for at least two weeks ...
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
The FDA added a warning to the label of esketamine nasal spray (Spravato), noting that long-term cognitive and memory ...
Nasacort 24HR Allergy Nasal Spray is the first product Dr. Randolph Betts, MD, a family medicine practitioner based in California, recommends for nasal congestion. He notes that almost all his ...
Researchers have developed a promising nasal spray therapy targeting neuroinflammation in Alzheimer’s disease, potentially ...
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback